Ir al inicio
  Inicio / Publicaciones / Publicaciones Cientificas Internacionales
 
 

PUBLICACIONES CIENTIFICAS INTERNACIONALES
IDENTIFICABLES EN PUB-MED.

Siguiente
 
 
364. Curtidor H, Patiño LC, Arévalo-Pinzón G, Vanegas M, Patarroyo ME, Patarroyo MA.
  Plasmodium falciparum rhoptry neck protein 5 peptides bind to human red blood cells and inhibit parasite invasion
  Peptides. 2013 Aug 8. doi:pii: S0196-9781(13)00268-4. 10.1016/j.peptides.2013.07.028. [Epub ahead of print]
363. Lozano JM, Guerrero YA, Alba MP, Lesmes LP, Escobar JO, Patarroyo ME.
  Redefining an epitope of a malaria vaccine candidate, with antibodies against the N-terminal MSA-2 antigen of Plasmodium harboring non-natural peptide bonds.
 

Amino Acids. 2013 Jul 9. [Epub ahead of print]
362. Moreno-Pérez DA, Saldarriaga A, Patarroyo MA.
  Characterizing PvARP, a novel Plasmodium vivax antigen.
  Malar J. 2013 May 20;12:165. doi: 10.1186/1475-2875-12-165.
361. Araujo Z, Giampietro F, Bochichio Mde L, Palacios A, Dinis J, Isern J, de Waard JH, Rada E, Borges R, Fernández de Larrea C, Villasmil A, Vanegas M, Enciso-Moreno JA, Patarroyo MA.
  Immunologic evaluation and validation of methods using synthetic peptides derived from Mycobacterium tuberculosis for the diagnosis of tuberculosis infection.
 

Mem Inst Oswaldo Cruz. 2013 Apr;108(2):131-9.
360. Moreno-Pérez DA, Ruíz JA, Patarroyo MA.
 

Reticulocytes: Plasmodium vivax target cells.
 

Biol Cell. 2013 Jun;105(6):251-60.

359.

Ocampo M, Patarroyo MA, Vanegas M, Alba MP, Patarroyo ME.
  Functional, biochemical and 3D studies of Mycobacterium tuberculosis protein peptides for an effective anti-tuberculosis vaccine.
  Crit Rev Microbiol. 2013 Feb 27. [Epub ahead of print]
358. Muñoz M, Camargo M, Soto-De Leon SC, Sanchez R, Parra D, Pineda AC, Sussmann O, Perez-Prados A, Patarroyo ME, Patarroyo MA.
  Human papillomavirus detection from human immunodeficiency virus-infected Colombian women's paired urine and cervical samples.
 

PLoS One. 2013;8(2):e56509.

357.

Arévalo-Pinzón G, Curtidor H, Muñoz M, Suarez D, Patarroyo MA, Patarroyo ME.
  Rh1 high activity binding peptides inhibit high percentages of Plasmodium falciparum FVO strain invasion.
 

Vaccine. 2013 Apr 3;31(14):1830-7.

356. Galvis-Jiménez JM, Curtidor H, Patarroyo MA, Monterrey P, Ramírez-Clavijo SR.
  Mammaglobin peptide as a novel biomarker for breast cancer detection.
  Cancer Biol Ther. 2013 Apr;14(4):327-32. doi: 10.4161/cbt.23614. Epub 2013 Jan 28.
355. Millán D, Chiriboga C, Patarroyo MA, Fontanilla MR.
  Enterococcus faecalis internalization in human umbilical vein endothelial cells (HUVEC).
 

Microb Pathog. 2013 Apr;57:62-9. doi: 10.1016/j.micpath.2012.11.007. Epub 2012 Nov 19.
354. Moreno-Pérez DA, Areiza-Rojas R, Flórez-Buitrago X, Silva Y, Patarroyo ME, Patarroyo MA.
  The GPI-anchored 6-Cys protein Pv12 is present in detergent-resistant microdomains of Plasmodium vivax blood stage schizonts.
 

Protist. 2013 Jan;164(1):37-48. doi: 10.1016/j.protis.2012.03.001. Epub 2012 May 2.
353.

Patarroyo MA, Calderón D, Moreno-Pérez DA.
  Vaccines against Plasmodium vivax: a research challenge.
  Expert Rev Vaccines. 2012 Oct;11(10):1249-60.
352. Patarroyo ME, Bermúdez A, Moreno-Vranich A.
  Towards the development of a fully protective Plasmodium falciparum antimalarial vaccine.
 

Expert Rev Vaccines. 2012 Sep;11(9):1057-70.

351.

Patarroyo ME, Moreno-Vranich A, Bermúdez A.
 

Phi (Φ) and psi (Ψ) angles involved in malarial peptide bonds determine sterile protective immunity.
  Biochem Biophys Res Commun. 2012 Dec 7;429(1-2):75-80
350. Patarroyo ME, Bermudez A, Alba MP.
  The high immunogenicity induced by modified sporozoites' malarial peptides depends on their phi (Φ) and psi (ψ) angles.
  Biochem Biophys Res Commun. 2012 Dec 7;429(1-2):81-6
349.

Garzón-Ospina D, López C, Forero-Rodríguez J, Patarroyo MA.
 

Genetic diversity and selection in three Plasmodium vivax merozoite surface protein 7 (Pvmsp-7) genes in a Colombian population.
  PLoS One. 2012;7(9):e45962.
348. Rodríguez DM, Ocampo M, Curtidor H, Vanegas M, Patarroyo ME, Patarroyo MA.
  Mycobacterium tuberculosis surface protein Rv0227c contains high activity binding peptides which inhibit cell invasion.
  Peptides. 2012 Dec;38(2):208-16. doi: 10.1016/j.peptides.2012.08.023. Epub 2012 Sep 19.
347.

Moreno-Vranich A, Patarroyo ME.
 

Steric-electronic effects in malarial peptides inducing sterile immunity.
 

Biochem Biophys Res Commun. 2012 Jul 13;423(4):857-62.

346. Munoz M, Camargo M, Soto-De Leon SC, Rojas-Villarraga A, Sanchez R, Jaimes C, Perez-Prados A, Patarroyo ME, Patarroyo MA.
  The diagnostic performance of classical molecular tests used for detecting human papillomavirus.
  J Virol Methods. 2012 Oct;185(1):32-8.
345. Ocampo M, Aristizábal-Ramírez D, Rodríguez DM, Muñoz M, Curtidor H, Vanegas M, Patarroyo MA, Patarroyo ME.
  The role of Mycobacterium tuberculosis Rv3166c protein-derived high-activity binding peptides in inhibiting invasion of human cell lines.
 

Protein Eng Des Sel. 2012 May;25(5):235-42.

344. Patarroyo ME, Almonacid H, Moreno-Vranich A.
  The role of amino acid electron-donor/acceptor atoms in host-cell binding peptides is associated with their 3D structure and HLA-binding capacity in sterile malarial immunity induction.
 

Biochem Biophys Res Commun. 2012 Jan 20;417(3):938-44.

343. Curtidor H, Arévalo-Pinzón G, Bermudez A, Calderon D, Vanegas M, Patiño LC, Patarroyo MA, Patarroyo ME.
 

Binding activity, structure, and immunogenicity of synthetic peptides derived from Plasmodium falciparum CelTOS and TRSP proteins.
 

Amino Acids. 2012 Jul;43(1):365-78.

342. Bermúdez A, Moreno-Vranich A, Patarroyo ME.
  Protective immunity provided by a new modified SERA protein peptide: its immunogenetic characteristics and correlation with 3D structure.
 

Amino Acids. 2012 Jul;43(1):183-94.

341. Urquiza M, Guevara T, Rodriguez C, Melo-Cardenas J, Vanegas M, Patarroyo ME.
 

Decreasing the configurational entropy and the hydrophobicity of EBV-derived peptide 11389 increased its antigenicity, immunogenicity and its ability of inducing IL-6.
  Amino Acids. 2012 Jun;42(6):2165-75. .
340. Ocampo M, Rodríguez DM, Curtidor H, Vanegas M, Patarroyo MA, Patarroyo ME.
  Peptides derived from Mycobacterium tuberculosis Rv2301 protein are involved in invasion to human epithelial cells and macrophages..
 

Amino Acids. 2012 Jun;42(6):2067-77. doi: 10.1007/s00726-011-0938-7. Epub 2011 May 19.
339. Arévalo-Pinzón G, Curtidor H, Muñoz M, Patarroyo MA, Bermudez A, Patarroyo ME.
  A single amino acid change in the Plasmodium falciparum RH5 (PfRH5) human RBC binding sequence modifies its structure and determines species-specific binding activity.
  Vaccine. 2012 Jan 11;30(3):637-46.
338.

Pérez-Cordero JJ, Lozano JM, Cortés J, Delgado G.
  Leishmanicidal activity of synthetic antimicrobial peptides in an infection model with human dendritic cells.
  Peptides. 2011 Apr;32(4):683-90.
337. Prajapati SK, Joshi H, Shalini S, Patarroyo MA, Suwanarusk R, Kumar A, Sharma SK, Eapen A, Dev V, Bhatt RM, Valecha N, Nosten F, Rizvi MA, Dash AP.
  Plasmodium vivax lineages: geographical distribution, tandem repeat polymorphism, and phylogenetic relationship.
 

Malar J. 2011 Dec 19;10:374.

336. Alba MP, Almonacid H, Calderón D, Chacón EA, Poloche LA, Patarroyo MA, Patarroyo ME.
 

3D structure and immunogenicity of Plasmodium falciparum sporozoite induced associated protein peptides as components of fully-protective anti-malarial vaccine.
 

Biochem Biophys Res Commun. 2011 Dec 16;416(3-4):349-55

335. Curtidor H, Vanegas M, Alba MP, Patarroyo ME.
  Functional, immunological and three-dimensional analysis of chemically synthesised sporozoite peptides as components of a fully-effective antimalarial vaccine.
  Curr Med Chem. 2011;18(29):4470-502. Review.
334.

Moreno-Perez DA, Montenegro M, Patarroyo ME, Patarroyo MA.
  Identification, characterization and antigenicity of the Plasmodium vivax rhoptry neck protein 1 (PvRON1).
  Malar J. 2011 Oct 24;10:314. doi: 10.1186/1475-2875-10-314.
333.

Restrepo-Montoya D, Becerra D, Carvajal-Patiño JG, Mongui A, Niño LF, Patarroyo ME, Patarroyo MA.
  Identification of Plasmodium vivax proteins with potential role in invasion using sequence redundancy reduction and profile hidden Markov models.
  PLoS One. 2011;6(10):e25189. doi: 10.1371/journal.pone.0025189. Epub 2011 Oct 3.
332. Camargo M, Soto-De Leon S, Sanchez R, Munoz M, Vega E, Beltran M, Perez-Prados A, Patarroyo ME, Patarroyo MA.
  Detection by PCR of human papillomavirus in Colombia: Comparison of GP5+/6+ and MY09/11 primer sets.
  J Virol Methods. 2011 Dec;178(1-2):68-74
 
Siguiente
 
     
Fundación Instituto de Inmunología de Colombia - FIDIC
Avenida 50 No. 26-20 - Bogotá D.C. - Colombia - Suramérica
(+57 1) 3158920 Ext 104 -106
Fax (+57 1) 3158920 Ext. 120 - (+57 1) 3244672 Email: info@fidic.org.co